FDA: Hospira recalls two lots of Naloxone Hydrochloride Injection
Editor's Note The Food & Drug Administration on June 4 announced the recall by Hospira, Inc, of two lots of its opioid antagonist Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL, Carpuject Single-use cartridge syringe system (NDC 0409-1782-69). The two lots, 72680LL and 76510LL, were recalled because…
FDA issues Class I Recall of CARDIOSAVE Hybrid Intra-aortic Balloon Pump by Maquet Datascope
Editor's Note The Food & Drug Administration on June 6 identified the recall by Maquet Datascope Corp of its CARDIOSAVE Hybrid Intra-aortic Balloon Pump as Class I, the most serious. The recall was initiated because of a design issue that allows fluid to seep into the device, which can lead…
FDA: New labeling for liquid-filled intragastric balloons
Editor's Note The Food & Drug Administration on June 4 announced that it had approved new labeling on potential risks for liquid-filled intragastric balloons by Apollo Endosurgery and ReShape Lifesciences. The new labeling for the Orbera and ReShape balloon systems includes more information about possible deaths linked to the use…
FDA: Recall of STAT-Check and Medline manual resuscitator bags
Editor's Note The Food & Drug Administration on June 1 announced the recall by SunMed Holdings of 18,808 units of its STAT-Check and Medline manual resuscitator bags. The recall was initiated because the patient port retaining ring of the bags may not fully seat, which could allow the patient port…
FDA: Class I recall of HeartWare HVAD system by Medtronic
Editor's Note The Food & Drug Administration on June 1 identified the recall by Medtronic of its HeartWare Ventricular Assist Device (HVAD) system as Class I, the most serious. The recall was initiated because of the possibility for an interruption to occur in the electrical connection between the system’s power…
FDA: Class I recall of HeartMate 3TM Left Ventricular Assist System
Editor's Note The Food and Drug Administration on May 22 identified the recall by Abbott of all lots of its HeartMate 3TM Left Ventricular Assist System as Class I, the most serious. The recall was issued because of a malfunction in the device’s outflow graft assembly that may cause the…
FDA: Class I recall of Medtronic’s MindFrame Capture LP revascularization device
Editor's Note The Food and Drug Administration (FDA) on May 18 identified the recall of Medtronic’s MindFrame Capture LP revascularization device as Class I, the most serious. Medtronic is recalling the device because there is a risk of the delivery wire breaking or separating during use. The clot retriever, which…
FDA: Class I recall of Vyaire Medical AirLife Resuscitation Device & Broselow Convenience Kit
Editor's Note The Food and Drug Administration (FDA) on May 11 announced the Class I recall, the most serious, of Vyaire Medical Inc's (Lake Forest, Illinois) AirLife Resuscitation Device & Broselow Convenience Kit. The recall was initiated because of an error in product design that may result in difficulty or…
FDA: AuroMedics Pharma recalls two lots of Piperacillin and Tazobactam for Injection
Editor's Note The Food and Drug Administration (FDA) on May 8 announced the recall by AuroMedics Pharma (Windsor, New Jersey) of two lots of Piperacillin and Tazobactam for Injection, USP 3.375 g in a single-dose vial. The vials were found to contain particulate matter after reconstitution that was confirmed to…
FDA: Class I recall of Fabius Anesthesia Machines by Dräger Medical
Editor's Note The Food and Drug Administration (FDA) on May 9 announced a Class I recall, the most serious, of Fabius Anesthesia Machines by Dräger Medical. The recall was initiated because of excessive oil that was not removed at the time of production. Excess oil may interfere with the position…
Free Daily News
- Study: High-paying medical specialty disparity persists as more women pursue surgical professions
- Study quantifies link between preoperative depression, postoperative delirium
- Cardiovascular disease trends raise alarms on primary care
- Study: Kidney transplants safe between donors, patients with HIV
- Study: Women more likely to die from postoperative complications after high-risk surgery
- Study: Same-day aquablation surgery safe for ASCs
- Outpatient, ASC clinicians share perspectives on upcoming NOPAIN Act implementation
- Study dispels orthopedic surgeon turnover myth
- Feds take action on Hurricane-wracked medical supply chain with wartime powers, drug compounding guidance
- Study: Wearable devices improve postoperative physical activity in lung cancer patients